Atossa Therapeutics
ATOS
#10757
Rank
NZ$35.09 M
Marketcap
NZ$3.52
Share price
-1.53%
Change (1 day)
152.69%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2026 (TTM): NZ-$7.02

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$7.45. In 2025 the company made an earnings per share (EPS) of NZ-$7.36 a decrease over its 2024 EPS that were of NZ-$5.54.

EPS history for Atossa Therapeutics from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$7.02-4.61%
2025NZ-$7.3632.89%
2024NZ-$5.54-15.56%
2023NZ-$6.5614.29%
2022NZ-$5.7416.67%
2021NZ-$4.92-90.86%
2020NZ-$53.85-2.96%
2019NZ-$55.49-63.09%
2018NZ-$150.33-49.63%
2017NZ-$298.48-57.87%
2016NZ-$708.47-74.01%
2015NZ-$2,726-9.18%
2014NZ-$3,001-12.86%
2013NZ-$3,44470.73%
2012NZ-$2,01734.07%
2011NZ-$1,505263.41%
2010NZ-$414.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.17-263.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$18.55-348.90%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$22.36-400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$0.46-93.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ-$0.38-94.87%๐Ÿ‡บ๐Ÿ‡ธ USA